Health Trials

Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET)

ConditionsDepressionCancerStage III Breast CancerStage II Breast CancerStage I Breast CancerStage III Prostate CancerStage II Prostate CancerStage I Prostate CancerStage III Colorectal CancerStage II Colorectal CancerStage I Colorectal Cancer
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorCase Comprehensive Cancer Center

About this trial

The purpose of this study is to develop and test a new intervention to reduce depressive symptoms in post-treatment cancer participants.

Eligibility criteria

Qualifiers

Self-reported mild to moderately-severe symptoms of depression (score 5-19 on PHQ-9).

A diagnosis of stage 0-III breast, prostate, or colorectal cancer.

Completion of primary cancer treatment within 2 years (excludes hormone therapy).

An ability to provide informed consent.

Disqualifiers

Self-reported minimal and severe depressive symptoms (<4 and > 20 on PHQ-9).

Self-reported suicidal ideation (>1 on item 9 PHQ-9).

Another psychological, medical, or other condition/issue determined that necessitates priority treatment and/or that would interfere with participation (e.g., schizophrenia, borderline personality disorder)

Current or recent substance abuse/dependence.

Trial design

Treatments tested in this trial

  • MINDSET
  • Enhanced Usual Care (EUC)

Treatment groups

76 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Case Comprehensive Cancer Center

Lead sponsor

Source ClinicalTrials.gov